Вы находитесь на странице: 1из 16

BLOOM SYNDROME

Presentation by: Grace OToole


aka: Bloom Torre Machacek syndrome

History of Bloom
1st identified by NY dermatologist Dr.
David Bloom

1st identified in 1954

Cause of Bloom

Autosomal recessive gene characterized by high levels of sister chromatids

Syndrome problem on chromosome 15


Cells have genomic instability with excessive homologous recombination Increase in chromosome breakage/rearrangement

Cause: BLM gene


Gene encoding protein

Mutation of BLM gene


Lack of BLM leads to
increase mutations

RecQL3 helicase

inactivate BLM proteins DNA helicase activity or nullify protein expression

Symptoms

Short stature

Clinical Features

Rash developing from sun exposure

High pitched voice


Facial features: long/narrow face, micrognathism (undersized jaw), prominent nose/ears Skin pigmentation change: hypo/hyper-pigment & cafeau-lait spots (pigmented birthmarks) Telangiectasis (dilation of capillaries to appear red) in eyes

Cont Skin Rash


Erythematous
(reddening), telangiectatic, infiltrated, & scaly shaped patch of skin across nose/cheek & back of hands

Appears in butterfly-

Cont Symptoms


Moderate immune deficiency {specifically immunoglobulin classes} leads to recurrent pneumonia & ear infection Hypogonadism (failure to produce sperm) so infertile males Premature menopause for women

Complications
-Chronic lung problems -Diabetes -Learning disabilities -Small # of mental retardation cases -Susceptibility to cancer

Elevated rate of Leukemia,


lymphomas, & carcinomas develop cancer approximately 25 years old

Bloom & Cancer

mutation brings high risk of cancer

Average age to

Identification
Confirmed
through lab test: chromosome study for chromosome 15

PCR assay test

Diagnosis Markers
Drastic
intrauterine growth deficiency with erythematous skin developing cancer

Small individual

Frequency
Found in larger
quantity in Ashkenazic Jews (carriers 1/100)

1/50,000 people

affected of Central and Easter European Jewish background

Possible carriers: Known carriers:


genetic counseling & genetic testing

Treatment for Identification

prenatal testing using cytogenetic or molecular methods

Treatment for Cases


No treatment Preventative Measures:
surveillance for cancer & decreased exposure to sunlight/X-rays marrow transplant

Possibility: bone

Bioethical Consequences
Ethical problems to consider: Gene testing to be carriers calls into
question for risk of child to be affected Bloom Syndrome child compared to child not afflicted

Sibling contempt with smaller sized

Bibliography a Baxter, Sarah. "BLM Gene Encodes

O'Neil, Marla J. "Bloom Syndrome;

RecQ Helicase." Davidson.edu. Davidson College Molecular Biology, n.d. Web. 25 Feb. 2013. <http://www.google.com/imgres?imgu rl=http://www.bio.davidson.edu/Cours es/Molbio/MolStudents/spring2003/B axter/BLM.gif>.

BLM." Omim. Omim, Oct.-Nov. 2009. Web. 25 Feb. 2013. <http://omim.org/entry/210900>.

Вам также может понравиться